Stock ORPHA ORPHAZYME A/S
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Orphazyme A/S

Equities

ORPHA

DK0062502894

Market Closed - Nasdaq Copenhagen
Other stock markets
 04:49:56 2024-05-17 am EDT 		5-day change 1st Jan Change
1,049 DKK -0.81% Intraday chart for Orphazyme A/S +3.88% -21.11%
Mar. 27 Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 04 FDA Extends Review of Zevra's Arimoclomol by Three Months DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORPHAZYME A/S Stock Orphazyme A/S
 5.4M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.84B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. ORPHA Stock
  4. Charts Orphazyme A/S
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW